Diethylcarbamazine PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Alters microfilarial surface membrane and neuromuscular function, enhancing host immune clearance of filarial parasites. It also has activity against adult worms depending on species and regimen.
Indications / reported uses
Treatment of lymphatic filariasis caused by susceptible Wuchereria bancrofti or Brugia species
Treatment of loiasis caused by Loa loa and selected other filarial infections under specialist guidance; dosing requires species identification and assessment of microfilarial burden
Identification source:PubChem record (CID 3052). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Diethylcarbamazine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Diethylcarbamazine Permitted Daily Exposure (PDE) report (the Diethylcarbamazine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Diethylcarbamazine Occupational Exposure Limit (OEL) report (the Diethylcarbamazine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.